Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Enoph1em1/Cya
Common Name:
Enoph1-KO
Product ID:
S-KO-12488
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Enoph1-KO
Strain ID
KOCMP-67870-Enoph1-B6N-VA
Gene Name
Enoph1
Product ID
S-KO-12488
Gene Alias
2310057D15Rik
Background
C57BL/6NCya
NCBI ID
67870
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:1915120
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Enoph1em1/Cya mice (Catalog S-KO-12488) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000169390
NCBI RefSeq
NM_026421
Target Region
Exon 2~5
Size of Effective Region
~4.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Enolase-phosphatase 1 (ENOPH1), a member of the HAD-like hydrolase superfamily, is an enzyme involved in L-methionine and polyamine biosynthesis [1,8,9]. It has been associated with stress responses, cell proliferation, and is linked to various physiological conditions such as neurological disorders [2,5,7]. It also activates signaling pathways like PI3K/AKT/mTOR and NF-κB [1,3]. Genetic models, especially knockout mice, have been crucial in studying its functions.

In glioma, ENOPH1 knockdown in cell lines inhibited cell proliferation and migration, and in an orthotopic glioma model, it suppressed tumor growth and prolonged survival, suggesting its role as an oncogenic driver [1]. In breast cancer, ENOPH1-silenced cell lines showed reduced proliferation, migration, and invasion, and its oncogenic properties were restrained when the NF-κB signaling pathway was inhibited [3]. In hepatocellular carcinoma, ENOPH1 down-regulation in vitro inhibited cell migration and invasion [4]. In cerebral ischemia, ENOPH1 knockout mice had ameliorated cerebral ischemic injury, decreased blood-brain barrier permeability, and inhibited extracellular matrix destruction [6]. Additionally, in ENOPH1 knockout mice after early ischemic stroke, changes in ubiquitination-modified proteins were observed, suggesting its role in regulating neuroinflammatory stress and barrier function [7].

In conclusion, ENOPH1 plays significant roles in cell proliferation, migration, and invasion across multiple cancer types like glioma, breast cancer, and hepatocellular carcinoma. In the context of cerebral ischemia, it is involved in blood-brain barrier dysfunction and neuroinflammatory stress. The use of ENOPH1 knockout mouse models has been instrumental in revealing these functions, providing potential therapeutic targets for cancer and ischemic stroke [1,3,4,6,7].

References:

1. Wang, Bo, Xu, Xin, Liu, Xi, Han, Tong, Hong, Jian. 2020. Enolase-phosphatase 1 acts as an oncogenic driver in glioma. In Journal of cellular physiology, 236, 1184-1194. doi:10.1002/jcp.29926. https://pubmed.ncbi.nlm.nih.gov/32654229/

2. Zhang, Xuezhong, Li, Ning, Chu, Tingting, Zhao, Haijun, Liu, Tonggang. 2025. Comprehensive pan-cancer analysis of ENOPH1 in human tumors. In Discover oncology, 16, 190. doi:10.1007/s12672-025-01965-x. https://pubmed.ncbi.nlm.nih.gov/39955431/

3. Bu, Yuhui, Hao, Jun, He, Jianchao, Liu, Yinfeng, Ma, Li. 2022. Tumor-promoting properties of enolase-phosphatase 1 in breast cancer via activating the NF-κB signaling pathway. In Molecular biology reports, 50, 993-1004. doi:10.1007/s11033-022-08066-w. https://pubmed.ncbi.nlm.nih.gov/36378417/

4. Zhuang, Hao, Qiang, Zhaoyan, Shao, Xiaowen, Wei, Wen, Li, Yongmei. 2019. Integration of metabolomics and expression of enolase-phosphatase 1 links to hepatocellular carcinoma progression. In Theranostics, 9, 3639-3652. doi:10.7150/thno.31693. https://pubmed.ncbi.nlm.nih.gov/31281503/

5. Iourov, Ivan Y, Zelenova, Maria A, Vorsanova, Svetlana G, Voinova, Victoria V, Yurov, Yuri B. . 4q21.2q21.3 Duplication: Molecular and Neuropsychological Aspects. In Current genomics, 19, 173-178. doi:10.2174/1389202918666170717161426. https://pubmed.ncbi.nlm.nih.gov/29606904/

6. Yang, Dexin, Su, Li, Li, Xiaofeng, Xie, Cong, Zhang, Yuan. 2023. Evidence that enolase-phosphatase 1 exacerbates early cerebral ischemia injury and blood-brain barrier breakdown by enhancing extracellular matrix destruction and inhibiting the interaction between ADI1 and MT1-MMP. In Experimental neurology, 365, 114410. doi:10.1016/j.expneurol.2023.114410. https://pubmed.ncbi.nlm.nih.gov/37075968/

7. Wu, Yike, Tang, Ping, Huang, Zhengzheng, Su, Li, Zhang, Yuan. 2025. Alteration of Ubiquitination in the Brain of ENOPH1 Knockout Mice after Early Ischemic Stroke. In Journal of proteome research, 24, 2349-2357. doi:10.1021/acs.jproteome.4c00913. https://pubmed.ncbi.nlm.nih.gov/40170525/

8. Su, Li, Yang, Ke, Li, Shun, Zhang, Yuan, Xu, Guozheng. 2018. Enolase-phosphatase 1 as a novel potential malignant glioma indicator promotes cell proliferation and migration. In Oncology reports, 40, 2233-2241. doi:10.3892/or.2018.6592. https://pubmed.ncbi.nlm.nih.gov/30066900/

9. Barth, Alexander, Bilkei-Gorzo, Andras, Drews, Eva, Wienker, Thomas F, Zimmer, Andreas. 2013. Analysis of quantitative trait loci in mice suggests a role of Enoph1 in stress reactivity. In Journal of neurochemistry, 128, 807-17. doi:10.1111/jnc.12517. https://pubmed.ncbi.nlm.nih.gov/24236849/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest